Key statistics
As of last trade Evolus Inc (EVL:FRA) traded at 15.10, -3.21% below its 52-week high of 15.60, set on Sep 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.70 |
---|---|
High | 15.10 |
Low | 14.70 |
Bid | 13.90 |
Offer | 14.10 |
Previous close | 14.50 |
Average volume | 1.17k |
---|---|
Shares outstanding | 63.09m |
Free float | 49.55m |
P/E (TTM) | -- |
Market cap | 1.04bn USD |
EPS (TTM) | -0.9073 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 14:18 BST.
More ▼
Press releases
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus to Hold Investor Day on September 12, 2024
- Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia
- Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Evolus to Report Second Quarter Financial Results on July 31, 2024
- Evolus Announces Appointment of Albert G. White III to Board of Directors
More ▼